Discover why Dynavax Technologies' stock dropped 25% despite HEPLISAV-B's growth & double-digit projections through 2030.

The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...

The global hepatitis c testing market revenue was around US$ 1.8 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...

Vir Biotechnology (NASDAQ:VIR) on Friday announced 24-week post-end-of-treatment data from a mid-stage trial for tobevibart ...

TUESDAY, May 6, 2025 (HealthDay News) -- Newborns can be effectively protected against respiratory syncytial virus (RSV) infection through the use of nirsevimab, a monoclonal antibody treatment, ...

THE WEEK’S MOST POPULAR CURRENT R&B/HIP-HOP SONGS ACROSS ALL GENRES ... Kendrick Lamar & SZA Last week Weeks at no. 1 Weeks on chart K.L.Duckworth, S.I.Rowe, A.Boggs, S.J.Dew, M.A.Spears ...

A recent case has been reported in Medicine of a patient with generalized pustular psoriasis (GPP) and hepatitis B whose flares were successfully ... “Spesolimab, an anti-IL-36 receptor monoclonal ...

Countries such as Thailand, Malaysia, Sri Lanka, and the Maldives have already achieved dual elimination of HIV and syphilis transmission from mother to child and are preparing for hepatitis B ...

Management is confident after Kimmtrak in combination with AstraZeneca’s (AZN) anti-PD-L1 antibody Imfinzi (durvalumab ... which targets hepatitis B virus. Initial early stage results are ...

Peter Tuchman, a prominent New York Stock Exchange floor trader who’s been known for his photogenic facial expressions, calls the mixed messaging out of the White House “economic terrorism ...